Surgery Partners Income Statement (2013-2025) | SGRY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	512.40M	543.30M	559.20M	610.20M	596.20M	615.40M	620.60M	707.10M	666.20M	667.60M	674.10M	735.40M	717.40M	762.10M	770.40M	864.40M	776.00M	826.20M	821.50M	885.00M
Cost of Revenue (Quarter)	147.30M	32.20M	160.10M	171.50M	171.60M	173.50M	173.20M	-361.60M	188.40M	182.20M	179.20M	195.20M	188.80M	45.40M	48.20M	-388.20M	215.80M	215.00M	208.90M	-438.30M
Gross Profit (Quarter)	365.10M	511.10M	399.10M	438.70M	424.60M	441.90M	447.40M	1,068.70M	477.80M	485.40M	494.90M	540.20M	528.60M	716.70M	722.20M	1,252.60M	560.20M	611.20M	612.60M	1,323.30M
Operating items
Depreciation & Amortization - Total (Quarter)
Selling, General & Administrative (Quarter)	26.80M	24.50M	25.50M	27.20M	29.50M	26.10M	17.90M	28.70M	32.00M	31.20M	36.80M	20.90M	33.20M	40.30M	29.20M	36.00M	36.00M	36.10M	22.40M	23.70M
Restructuring Costs (Quarter)	5.30M	9.20M	10.20M	15.10M	7.10M	8.20M	12.50M	19.70M	12.50M	12.00M	12.80M	24.40M	17.40M	19.30M	29.40M	34.00M	24.70M	18.10M	12.60M	18.50M
Other Operating Expenses (Quarter)					32.80M			-3.50M	-3.00M	-1.50M	-3.60M	-2.50M	1.80M	-0.50M	-0.50M		-2.20M		-5.10M
Operating Expenses (Quarter)	448.10M	483.80M	495.60M	495.40M	495.80M	480.80M	489.40M	522.80M	532.20M	513.50M	591.50M	541.80M	641.40M	677.30M	592.90M	340.50M	614.10M	630.60M	715.80M	1,048.30M
Operating Income (Quarter)	64.30M	59.50M	63.60M	114.80M	100.40M	76.50M	74.10M	94.20M	46.40M	97.60M	82.60M	101.40M	76.00M	84.80M	60.90M	127.10M	61.90M	111.70M	105.70M	110.20M
EBIT (Quarter)	64.30M	59.50M	63.60M	114.80M	100.40M	76.50M	74.10M	94.20M	46.40M	97.60M	82.60M	101.40M	76.00M	84.80M	60.90M	127.10M	61.90M	111.70M	105.70M	110.20M
Non-operating items
Interest & Investment Income (Quarter)	-53.30M	-53.40M	-54.20M	-60.10M	-56.30M	-56.90M	-60.70M	-61.00M	-46.80M	-47.70M	-49.80M	-48.70M	-47.30M	-51.50M	-50.00M	-52.90M	-62.20M	-67.90M	-74.90M	-67.60M
Other Non Operating Income (Quarter)		-9.60M	0.50M					-13.90M				-15.50M		-5.10M					-1.30M
Net income details
EBT (Quarter)	11.00M	6.10M	9.40M	54.70M	44.10M	19.60M	13.40M	33.20M	-0.40M	49.90M	32.80M	52.70M	28.70M	33.30M	10.90M	74.20M	-0.30M	43.80M	30.80M	42.60M
Tax Provisions (Quarter)	0.20M	-2.70M	1.20M	11.80M	1.30M	4.30M	7.80M	9.90M	-1.60M	-7.80M	3.10M	6.00M	4.40M	4.90M	4.50M	120.80M		-1.10M	5.50M	13.60M
Profit After Tax (Quarter)	-21.00M	-26.90M	8.20M	141.50M	42.80M	-18.40M	5.60M	-118.30M	1.20M	57.70M	-4.90M	-1.00M	24.30M	28.40M	-31.70M	-108.50M	-0.30M	44.90M	-22.70M	161.80M
Equity Income (Quarter)	2.60M	3.00M	2.90M	2.80M	3.10M	2.60M	2.40M	4.40M	3.30M	2.60M	3.50M	4.80M	2.70M	4.40M	5.20M	7.20M	5.60M	5.50M	5.20M	6.60M
Income from Non-Controlling Interests (Quarter)	31.80M	35.70M	31.10M	43.00M	30.60M	33.70M	30.60M	46.70M	26.10M	38.80M	34.60M	47.70M	36.70M	43.90M	38.10M	61.90M	37.40M	47.40M	48.00M	44.00M
Income from Continuing Operations (Quarter)	10.80M	8.80M	8.20M	42.90M	42.80M	15.30M	5.60M	23.30M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M
Consolidated Net Income (Quarter)	10.80M	8.80M	8.20M	42.90M	42.80M	15.30M	5.60M	23.30M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M
Income towards Parent Company (Quarter)	10.80M	8.80M	8.20M	42.90M	42.80M	15.30M	5.60M	23.30M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M
Preferred Dividend Payments (Quarter)	10.30M
Net Income towards Common Stockholders (Quarter)	-31.30M	-26.90M	-22.90M	-0.10M	12.20M	-18.40M	-25.00M	-23.40M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M
Additional items
EPS (Basic) (Quarter)	-0.57	-0.39	-0.28	0.07	0.14	-0.21	-0.28	-0.24	-0.20	0.15	-0.04	0.37	-0.10	-0.12	-0.25	-0.86	-0.30	-0.02	-0.18	-0.11
EPS (Weighted Average and Diluted) (Quarter)	-0.57	-0.39	-0.28	0.07	0.14	-0.21	-0.28	-0.24	-0.20	0.15	-0.04	0.37	-0.10	-0.12	-0.25	-0.86	-0.30	-0.02	-0.18	-0.11
Shares Outstanding (Weighted Average) (Quarter)	54.77M	62.06M	80.73M	72.43M	88.00M	88.90M	88.91M	91.95M	125.21M	125.72M	125.56M	125.61M	125.97M	126.13M	126.09M	126.12M	126.60M	126.79M	126.93M	127.21M
Shares Outstanding (Diluted Average) (Quarter)	54.77M	62.06M	68.35M	72.43M	90.27M	88.45M	88.91M	91.95M	125.21M	127.37M	125.75M	125.61M	125.97M	126.13M	126.17M	126.12M	126.60M	126.98M	127.21M	127.21M
EBITDA (Quarter)	64.30M	59.50M	63.60M	114.80M	100.40M	76.50M	74.10M	94.20M	46.40M	97.60M	82.60M	101.40M	76.00M	84.80M	60.90M	127.10M	61.90M	111.70M	105.70M	110.20M
Tax Rate (Quarter)	1.82%	-44.26%	12.77%	21.57%	2.95%	21.94%	58.21%	29.82%	400.00%	-15.63%	9.45%	11.39%	15.33%	14.71%	41.28%	162.80%		-2.51%	17.86%	31.92%

Research Tools

Surgery Partners Income Statement (2013-2025) | SGRY

Create an account

Sign In

Reset Password